Health

Global Vaccines Research

As the race to develop a COVID-19 vaccine continues at speed, the world faces many more questions than answers – not only about when we might have a vaccine, but who will get it first, how will they get it and are they willing to have it? And how far will it take us on the journey back to ‘normal’…?

1 November 2020

As we await the most anticipated vaccine in modern history, Ipsos continues to conduct research among consumers, healthcare professionals and other stakeholders to understand the dynamics around COVID-19 vaccines – and hence, the future outlook – through the eyes of society, markets and people.

Find our latest insights and opinions and an overview of our global vaccines research offer below.

Polls & Reports | Articles & Papers | Services

Polls & Reports

COVID-19 vaccination intent is decreasing globally. Most adults across 15 countries don’t expect a vaccine to be available any sooner than mid-2021; only half would get vaccinated within three months of its availability - 5 November
Coronavirus misinformation and reckless behaviour linked. New Axios-Ipsos poll in the U.S. shows celebrating upcoming holidays seen as somewhat risky – 20 October
Interest in COVID-19 vaccine waning. New Newsy/Ipsos poll shows COVID-19 pandemic has bolstered support for public health funding, but not in the form of a tax increase in the USA – 25 September
Two in three Americans likely to get coronavirus vaccine. New ABC News/Ipsos poll shows the number of Americans planning to get vaccinated, while still a majority, has declined from May – 20 September
3 in 4 Australians support mandatory COVID-19 vaccination. Following on from a recent Ipsos Study on behalf of the World Economic Forum which showed 88% of Australian adults surveyed would get a vaccine for COVID-19 if it were available, new data shows strong support for mandatory vaccination – 8 September
Three in four adults globally say they would get a vaccine for COVID-19. Most do not expect any will be available before the end of year; fear of side effects is top reason for not wanting to take the vaccine – 1 September
The race for a vaccine. In the turbulent times of COVID-19, businesses need to make critical decisions quickly. Synthesio and Ipsos are closely tracking millions of conversations to help our clients make informed, timely decisions – 20 August
COVID-19 Vaccine Research. Almost three in four people would get COVID-19 vaccine, says Ipsos in Ireland survey for IPHA – 13 July

Articles & Papers

Vaccines hesitancy: Understanding belief formation – As we await the progress of COVID-19 vaccines, one question we can usefully consider now is how vaccination beliefs and behaviours are formed and maintained. This paper looks at the issue of vaccines hesitancy from a behavioural science perspective and asks whether the discussion to date has been overly focused on the individual, underestimating the role of cultural and political situations and other social drivers.

Great expectations: Developments & dynamics of a COVID-19 vaccine – coming soon

Informed by insights from Ipsos research and other sources, this paper summarises our current situation and the dynamics surrounding COVID-19 vaccines in development, the likely future uptake and, ultimately, impact.